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Abstract
Protein phosphorylation is deeply involved in the pathological mechanism of various neurodegenerative disorders.
However, in human pathological samples, phosphorylation can be modified during preservation by postmortem factors
such as time and temperature. Postmortem changes may also differ among proteins. Unfortunately, there is no
comprehensive database that could support the analysis of protein phosphorylation in human brain samples from the
standpoint of postmortem changes. As a first step toward addressing the issue, we performed phosphoproteome analysis
with brain tissue dissected from mouse bodies preserved under different conditions. Quantitative whole proteome mass
analysis showed surprisingly diverse postmortem changes in phosphoproteins that were dependent on temperature, time
and protein species. Twelve hrs postmortem was a critical time point for preservation at room temperature. At 4uC, after the
body was cooled down, most phosphoproteins were stable for 72 hrs. At either temperature, increase greater than 2-fold
was exceptional during this interval. We found several standard proteins by which we can calculate the postmortem time at
room temperature. The information obtained in this study will be indispensable for evaluating experimental data with
human as well as mouse brain samples.
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Introduction
Protein phosphorylation has been implicated widely in the
pathological mechanisms of neurodegenerative disorders including
Alzheimer’s disease (AD), frontotemporal dementia (FTD),
dementia with Lewy bodies (DLB), Parkinson’s disease dementia
(PDD), and Huntington’s disease (HD). For instance, hyperpho-
sphorylated forms of tau have been identified as a major
component of paired helical filament (PHF) [1], the common
pathological hallmark of AD and tau-associated FTD. Hyperpho-
sphorylation impairs the microtubule binding of tau and
destabilizes microtubules. A process mediated by various serine/
threonine kinases such as GSK3beta, PKA, Cdk5 and casein
kinase II might also accelerate aggregation of tau into PHF [2–5].
In the DLB brain, phosphorylated alpha-synuclein at Ser 129 has
been detected by mass spectrometry and phosphorylation-
accelerated aggregation of alpha-synuclein has been shown in vitro
[6]. The increase of toxicity by phosphorylation was also suspected
in a Drosophila model of PDD [7].
However, the significance of variable phosphorylation levels of
inclusion body component proteins remains controversial. For
instance, in alpha-synuclein, phosphorylated tyrosine and serine
residues seem to have opposite effects on cellular toxicity [8]. In
addition, the role of phosphorylation can differ among neurode-
generative diseases. In contrast to the cases of tau and synuclein,
phosphorylation of mutant huntingtin (Htt) at Ser 421 in response
to IGF treatment reduced toxicity [9]; similarly, phosphorylation
of Htt at Ser 13 and 16 alleviated phenotype in a mouse model of
HD [10].
Furthermore, one can easily imagine that a number of
phosphoproteins other than aggregated proteins would quantita-
tively change in the context of neurodegenerative disorders. It is
possible that such phosphorylation also affects neurodegeneration.
Therefore, in order to understand the whole scheme of
pathological functions of protein phosphorylation, it is necessary
to perform a full ‘‘omics’’ analysis of phosphoproteins in human
brains.
However, the most significant obstacle to this approach is posed
by the preservation conditions of human brains. There is no world
standard that specifies how to preserve postmortem human bodies
before the brains are cut, frozen and kept in the brain bank. After
patients’ deaths, their bodies are left on their beds at room
temperature for different length of time before being transferred to
the morgue in the pathology department. The time between brain
sectioning and freezing on dry ice also varies among samples and
among institutions.
Therefore, we need to know how the phosphoproteome changes
in postmortem brains during the process of preservation. Based on
such knowledge, we could potentially design a specific preservation
protocol for brain banks to follow in order to enable reproducible
phosphoproteome analysis in human samples. Even with such a
standard, specific methods for adjusting phosphoproteomic data
based on time and temperature would also be required. For these
purposes, we performed proteome-wide analyses of phosphopro-
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4uC for different lengths of time. The results reveal surprisingly
diverse patterns of chronological changes of phosphoproteins.
Data such as ours will be crucial in interpreting the phosphopro-
tein data obtained to date, as well as future data, from human
brain samples.
Results
Diverse changes of postmortem phosphoproteins
To investigate the effect of postmortem time on phosphopro-
teins before the brain was isolated and frozen, we kept 12 week-old
C57BL/6J mice at 25uCo r4 uC for a different length of time (0, 3,
12, 72 hrs) after they were sacrificed by deep euthanasia. After the
incubation period, the mice were dissected and their brains
immediately frozen in liquid nitrogen. The brain samples were
thawed at 4uC in T-PER Tissue Protein Extraction Reagent and
immediately used for sample preparation, as described in
Methods. The quantitative whole proteome mass analysis was
performed with Q-STAR (AB SCIEX) and repeated for three sets
of samples. Each set included cerebral cortex samples from a
mouse body kept at 25uCo r4 uC for different lengths of time (0, 3,
12, 72 hrs).
Relative quantity compared to the initial value at 0 hr was
obtained for each phosophoprotein, and the mean value among
three sets was calculated for each time point and temperature
(Figure 1). Surprisingly, the postmortem changes in phosphopro-
teins showed extreme diversity (Figure 1). When increase and
decrease were defined as more than 1.2 and less than 0.8 fold,
respectively, 26% of total phosphoproteins decreased rapidly from
0 to 3 hrs, while 17% of proteins increased during this interval at
room temperature (25uC). 75% of total phosphoproteins were
reduced after more than 12 hrs at room temperature (25uC), but
some exceptional phosphoproteins (5.5%) continued to increase
from 12 to 72 hrs. In contrast to the pattern at room temperature,
55% of phosphoproteins were relatively stable after more than
12 hrs at 4uC. However, there were also exceptional cases whose
levels increased or decreased rapidly.
Categorization of temperature-dependent changes of
phosphoproteins
We suspected that a mixture of different patterns might cause
the extreme diversity of chronological changes. Therefore, we
categorized the data by cluster analysis. At each temperature,
phosphoproteins were classified into four groups (Figure 2).
Group A2C showed typical patterns at each temperature, while
group D (‘‘miscellaneous’’) contained a wide variety of behaviors.
At room temperature, Group A exhibited a transient increase and
decline after 12 hrs. Group B exhibited a relatively constant and
slow decrease until 72 hrs. Group C exhibited a rapid decrease
until 12 hrs and a more gradual decrease after 12 hrs. At 4uC,
Group A tended to increase slowly; group B was almost stable
until 72 hrs; and group C decreased rapidly until 3 hrs and then
stabilized.
The classification revealed that in each temperature group, the
initial changes in phosphoprotein levels followed diverse paths
until 12 hrs. Later than 12 hrs, all phosphoproteins either
stabilized or gradually decreased at room temperature. At the
same time, there were exceptional proteins whose changes can
hardly be expected. These patterns of change were also supported
when proteins were classified by the ratio of changes (Figure 3).
Until 12 hrs, the percentage of increased (X.1.2), unchanged
(0.8,X,1.2) or decreased (X,0.8) phsophoproteins was almost
the same between 25uC and 4uC. However, the percentage of
decreased proteins (X,0.8) increased markedly at times later than
12 hrs at 25uC.
As shown in Figure 2, the pattern for Group B at 25uC looked
similar to that of Group B at 4uC. This was also the case for Group
C. This impression was supported by a comparison of phospho-
proteins belonging to these groups (Figures S1, S2, S3). The
comparison also indicated that expression of a majority of proteins
was relatively constant, and that chronological change can be
expected at both temperatures.
Selection of standard phosphoproteins
We next selected standard proteins that can be used for
quality control of brain tissue even when information about
postmortem processing conditions is not available. We first
plotted the mean value of each group (Figures 4, 5). The mean
value for total protein level declined at 0.006/hr after 12 hrs at
25uC (Figure 4); in contrast, at 4uC, the mean value was stable
until 72 hrs (Figure 5). Corresponding to each group, we selected
representative proteins that mimicked the pattern of mean values
(Figures 4, 5). The standard proteins that represented the decline
of total phosphoproteins at room temperature were Glud1,
Pacsin1 and Snap25. Glud1 is highly expressed in the brain and
is known to function as a mitochondrial enzyme converting
glutamate to 2-oxoglutarate [11], thereby affecting the blood
ammonia level [12]. Pacsin1, a neural isoform of Pacsin, is a
cytoplasmic phosphoprotein involved in vesicle formation [13]
and endocytosis regulation [14]. It also interacts with huntingtin
at synapses [15]. Snap25 is a membrane-bound pre-synaptic
protein and a component of the SNARE complex [16], which is
essential for synaptic vesicle fusion [17] and Ca
2+ response [18].
On the other hand, the standard proteins representing the
stability of total phosphoproteins at 4uC were Pacsin1, Eefeld
and Prpsap2. Eefeld delivers aminoacyl tRNAs to the ribosome
[19], and is also known to catalyze the exchange of GDP bound
to Elongation Factor 1a with GTP [20] which is stimulated by
PKC [21]. Prpsap2 negatively regulates phosphoribosyl pyro-
phosphate (PRPP) synthetase [22]. These data together indicate
that Pacsin1 is a good control protein to use in evaluation of the
postmortem interval during which the body was left at room
temperature before transfer to the morgue in the pathology
department.
We also found several phosphoproteins that were relatively
stable up to 72 hrs at room temperature (Figure 6). Importantly,
one of them, Gm5506 (a-enolase) was stable also at 4uC (Figure 6).
As shown in Figures 4 and 5, the change of Pacsin1 exactly
matches with the average change of total phosphoprotein
(Figures 4, 5). Pacsin1 decreases at a constant rate at room
temperature but it is stable at 4uC for 72 hrs. In contrast, Gm5506
is stable both at room temperature and 4uC. The ratio between the
absolute signal values of Pacsin1 and Gm5506 at 0 hr (76.1:75.1) is
also known. From these values, we can calculate the postmortem
time at room temperature according to the formula (Figure 7).
Discussion
This study had three main goals: 1) to investigate how the
phosphoproteome is changed in postmortem brains over the
course of preservation; 2) to propose a specific preservation
protocol that is suitable for phosphoproteome analysis of brain
tissue; 3) to develop a specific method for adjusting phosphopro-
tein data based on time and temperature. For these purposes, we
performed whole-proteome analyses of phosphoproteins using
mouse brains that had been kept at room temperature or 4uC for
different lengths of time.
Postmortem Change of Brain Phosphoproteome
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21405First, we learned that the chronological changes in phospho-
proteins are surprisingly diverse. Most proteins (82.5% at RT and
93.7% at 4uC) change following several typical patterns (Group A,
B or C). However, the change of the other proteins is hardly
prospected (Group D). This result suggests several things. If a
phosphoprotein of interest belongs to the three regular groups
(Groups A2C), we can evaluate whether the value obtained in an
experiment is increased or decreased based on the pattern
obtained in this study. If a target phosphoprotein in future
research belongs to Group D, however, caution must be taken in
evaluating its levels. Although the patterns are limited to 126
proteins in our current study, the database would be expanded to a
larger number of phosphoproteins. We are now obtaining data
with a higher grade of mass analysis; the results will be made
available as an open database in the future.
As hyperphosphorylation of some specific proteins has been
implicated as causative in neurodegenerative disorders, we asked
whether our current results included such important proteins.
However, APP [23-27], Presenilin1/2 [28,29], tau [30,31],
Apolipoprotein E [32], Cdk5 [33], TDP-43 [34] or GSK-3beta
[35], which are implicated in Alzheimer’s disease and tauopathy,
were not included in these results. Also, alpha-synuclein [36,37],
Leucine-rich repeat kinase 2 [38,39], ubiquitin carboxyl-terminal
hydrolase L1 [40], Parkin [41], Pink1 [42], Grb10-Interacting
GYF Protein-2 [43], or Omi/HtrA2 [44], which are implicated in
Parkinson’s disease, are not included. The postmortem changes in
these proteins will also become clear in a future study.
Although postmortem changes in phosphoproteins were diverse
over the first 12 hrs, they were generally inclined to decrease from
12 to 72 hrs. Since only one protein was increased more than
Figure 1. Postmortem dynamics of phosphoproteins revealed by quantitative mass analysis. The numbers of proteins and peptides
identified from three sets of mass analysis are listed. 126 proteins were identified with more than 95% fidelity from the merged data of three sets. The
lower graphs show the chronological change of phosphoproteins during preservation at 25uC and 4uC.
doi:10.1371/journal.pone.0021405.g001
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PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21405Figure 2. Cluster analysis of postmortem phosphoprotein dynamics. Dendrograms of total identified proteins at RT (25uC) and 4uC were
drawn by cluster analysis. Cerebral cortex phosphoproteins were classified into four groups according to the changing pattern (upper panels). At
25uC, 34, 46, 24 and 22 proteins belong to Groups A, B, C and D, respectively. At 4uC, 33, 64, 21 and 8 proteins belong to Groups A, B, C and D,
respectively. Lower graphs show the patterns of chronological change for phosphoproteins in each group.
doi:10.1371/journal.pone.0021405.g002
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were increased more than 2-fold during 72 hrs at 4uC, increases
more than 2-fold can be suspected as abnormal in any postmortem
samples that were kept at 4uC within 72 hrs. However, after
getting such a result, one should come back to postmortem omics
data such as ours in order to check the validity of the result.
Second, we can now propose how the brain samples should be
prepared for the analysis of phosphoproteins. Our results showed
that some proteins rapidly decreased within 12 hrs at room
temperature (Figure 2, Group C at RT) while some other proteins
increased within 12 hrs at room temperature (Figure 2, Group A at
RT). After 12 hrs, most phosphoproteins declined at a constant rate
(0.006/ hr), and we learned that the mean value of phosphoproteins
at room temperature wasremarkablydecreased at 72 hrs (Figure 3).
Even at 4uC, some proteins were increased or decreased within
12 hrs (Figure 2, Groups A2Ca t4 uC). Later than 12 hrs,
however, the amounts of phosphoprotein were very stable
(Figure 2, Groups A2Ca t4 uC). This probably means that it
takes some time before the brain temperature reaches 4uC, and
some phosphoproteins change quantitatively during the time. But
after the brain temperature was brought to 4uC, phosphoproteins
were stable until 72 hrs. Measurement of postmortem deep brain
temperature supported this speculation (Figure S4).
Thus, the body should be chilled to 4uC as soon as possible, no
later than 12 hrs after death. In other words, the brain
temperature should become 4uC within 12 hrs postmortem. Even
with more or less immediate chilling, however, one should refer to
our database in this study (Figure S5) showing how each
phosphoprotein changes over the course of the first 12 hrs. We
will update the database, covering far more phosphoproteins, in
the near future.
Third, we propose a method for estimating the postmortem
time spent at room temperature. Pacsin1 decreases at a constant
rate at room temperature, exactly matching with the average
change of total phosphoprotein (Figures 4, 5). In addition, Pacsin1
is stable at 4uC for 72 hrs. In contrast, Gm5506 is stable both at
room temperature and 4uC. The absolute signal value ratio
between Pacsin1 and Gm5506 at 0 hr (76.1:75.1) is also known.
Therefore, we could calculate the postmortem time at room
temperature from these values (Figure 7). We would be able to use
Eefeld and Prpsap2, as well as Hspa8/Hsp70-4 or 14-3-3 a/b,a s
other standards for the same purpose. If we can obtain a fresh
human brain sample and measure the absolute ratio between
Pacsin1 and Gm5506/a-enolase at 0 hr, this method can be used
to calculate the postmortem time in humans. However, for ethical
reasons, we have not obtained such a value currently.
Figure 3. Comparison between RT and 46C groups. (A) Identified phosphoproteins at each time point were classified into three groups based
on the relative quantity to the initial value at 0 hr. (B) Corresponding groups are compared between RT (25uC) and 4uC to evaluate the similarity
between groups.
doi:10.1371/journal.pone.0021405.g003
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have to add earlier time points to detect certain unexpected
changes of phosphoproteins. Second, we need to analyze other
parts of the brain like brainstem, cerebellum, and spinal cord. The
dynamics of phosphoproteins in such brain parts might be
different from that of cerebral cortex. The information will be
necessary for the phosphoprotein in human diseases like
spinocerebellar ataxia or multiple system atrophy.
In conclusion, our data has provided crucial information that can
be used to interpret future data, as well as previously reported
experimental data regarding phosphoproteins. We may have to re-
evaluate previous reports using human samples from the standpoint
of postmortem time and temperature. Future experiments using
human samplesshould definitely be evaluated usingour data, which
will be expanded and delivered as an open database.
Materials and Methods
Ethics statement
All procedures were approved by the Institutional Animal Care
and Use Committee of the Tokyo Medical and Dental University
(MR:2010-002) and performed according to the guidelines of
Ministry of Education, Culture, Sports, Science and Technology
(MEXT) of Japanese government.
Sample preparation
12 week-old C57BL/6J mice were kept at 25uCo r4 uC for
different lengths of time (0, 3, 12, 72 hrs) after they were sacrificed
by deep euthanasia using ethyl ether. Mice were put in a glass
bottle (5L) in which the air was saturated by ethyl ether. The mice
were deeply anesthetized by ether vapor at three minutes later
Figure 4. Representative genes of each clustered group at RT. Chronological changes at 25uC of the mean value of total identified
phosphoproteins (Total) and of phosphoproteins belonging to each group (Groups A2D) are shown. Proteins most similar to the mean value pattern
were also selected.
doi:10.1371/journal.pone.0021405.g004
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immediately frozen in liquid nitrogen, and stored at 280uC.
Protein was extracted from the cerebral cortex using the T-PER
Tissue Protein Extraction Reagent (Thermo Fisher Scientific Inc.,
USA). The amount of the protein was measured using the BCA
Protein Assay Reagent (Thermo Fisher Scientific Inc.).
iTRAQ labeling
Samples containing 95 mg of protein were denatured in 0.1%
SDS, and reduced in 5 mM TCEP (tris-2-carboxyethyl phosphine)
for 1 hr at 60uC. Cysteine residues were blocked with 10 mM
MMTS (methyl methanethiosulfonate) for 10 min at 25uC, and
then samples weredigested with trypsin (10:1 protein/enzyme w/w)
for 24 hrs at 37uC. The digested proteins (peptides) were then
passed through a Sep-Pak Light C18 cartridge column (Waters
Corporation, USA) to be desalted. Phosphopeptides were enriched
using the Titansphere Phos-Tio Kit (GL Sciences Inc., Japan), and
desalted again with a Sep-Pak Light C18 cartridge column. The
peptides in each individual sample were labeled separately using the
iTRAQ Reagent-multiplex assay kit (AB SCIEX Ins.) for 2 hrs at
25uC. The labeled peptide pools were then mixed together. Next,
the peptide mixture was subjected to SCX (Strong Cation
Exchange) chromatography (AB SCIEX Ins.). The peptide mixture
was eluted in a stepwise gradient from 20, 60, 100, 150, 200, and
350 mM KCl in 10 mM KH2PO4 (pH 3.0), 25% acetonitrile. The
peptidefractionswere driedand desaltedusingaSep-PakLightC18
cartridge column.
Quantitative whole proteome mass analysis
The dried peptide fractions were re-suspended in 2%
acetonitrile and 0.1% formic acid. Each SCX fraction was
analyzed using a DiNa Nano-flow LC system (KYA Technologies
Figure 5. Representative genes of each clustered group at 46C. Chronological changes at 4uC of the mean value of total identified
phosphoproteins (Total) and of phosphoproteins belonging to each group (Groups A2D) are shown. Representative proteins that mimic the mean
value pattern are also selected.
doi:10.1371/journal.pone.0021405.g005
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System (AB SCIEX Ins.). The samples were loaded onto a
0.1 mm6100 mm C18 column and eluted with a gradient of
52100% solution B (80% acetonitrile and 0.1% formic acid) in
solution A (2% acetonitrile and 0.1% formic acid). The flow rate
was 300 nL/min, and ion spray voltage was 1.8 kV. The IDA
Figure 6. Stable proteins at RT and 46C. Proteins whose relative amount stayed within 0.8 to 1.2 during 72 hrs are listed. 7 and 36 proteins
matched this criterion at 25uC and 4uC, respectively. Proteins found at both temperatures are marked in red. Arrows indicate the standard protein,
which is stable at RT (25uC) and 4uC.
doi:10.1371/journal.pone.0021405.g006
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with two to four charges. Analyst QS 2.0 software (AB SCIEX
Ins.) was used to identify each peptide. Quantification of each
peptide was based on TOF-MS electric current detected during
the LC-separated peptide peak, adjusted by the charge/peptide
ratio. Quantification of a protein was deduced by averaging the
quantities of multiple peptide peaks from the protein. These
processes were automatically performed using the Q-STARH Elite
Hybrid LC/MS/MS Hybrid System (AB SCIEX Ins.)
Cluster analysis of identified proteins
The quantitative ratio between 0 hr and the other 6 time points
(1, 25uC for 3 hrs; 2, 25uC for 12 hrs; 3, 25uC for 72 hrs; 4, 4uC
for 3 hrs; 5, 4uC for 12 hrs; 6, 4uC for 72 hrs) in each detected
protein was obtained using the Protein Pilot software (AB SCIEX
Ins.) analysis. The chronological pattern was classified into four
groups by clustering analysis using Minitab 16 software with the
Ward method and Euclidean distance. Dendrograms were drawn
using the same software.
Supporting Information
Figure S1 Proteins belonging to each cluster group at 25uC are
listed. Proteins that are members of the same groups at 25uC and
4uC are marked in red.
(TIF)
Figure S2 Proteins belonging to each cluster group at 4uC are
listed. Proteins that are members of the same groups at 25uC and
4uC are marked in red.
(TIF)
Figure S3 Full names of the gene symbols, listed in alphabetical
order.
(TIF)
Figure S4 Chronological change of the deep brain temperature
in mouse body at 25uCo r4 uC. Temperature was measured using
a needle thermometer (Testo 905-T1, Japan) in mouse bodies left
at 25uCo r4 uC and mean +/2 SD (n=4) are shown in the graph.
(TIF)
Figure S5 The Excel file includes all the data on 126 proteins.
(TIF)
Author Contributions
Conceived and designed the experiments: HO. Performed the experi-
ments: TO KT HI. Analyzed the data: TO KT. Wrote the paper: TO
HO.
References
1. Nukina N, Ihara Y (1985) Proteolytic fragments of Alzheimer’s paired helical
filaments. J Biochem 98: 1715–1718.
2. Masliah E, Iimoto DS, Mallory M, Albright T, Hansen L, et al. (1992) Casein
kinase II alteration precedes tau accumulation in tangle formation. Am J Pathol
140: 263–268.
3. Hanger DP, Byers HL, Wray S, Leung KY, Saxton MJ, et al. (2007) Novel
phosphorylation sites in tau from Alzheimer brain support a role for casein
kinase 1 in disease pathogenesis. J Biol Chem 282: 23645–23654.
4. Wang JZ, Grundke-Iqbal I, Iqbal K (2007) Kinases and phosphatases and tau
sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25:
59–68.
5. Piedrahita D, Herna ´ndez I, Lo ´pez-Tobo ´n A, Fedorov D, Obara B, et al. (2010)
Silencing of CDK5 reduces neurofibrillary tangles in transgenic Alzheimer’s
mice. J Neurosci 30: 13966–13976.
6. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, et al. (2002)
alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:
160–164.
7. Chen L, Feany MB (2005) Alpha-synuclein phosphorylation controls neurotox-
icity and inclusion formation in a Drosophila model of Parkinson disease. Nat
Neurosci 8: 657–663.
8. Chen L, Periquet M, Wang X, Negro A, McLean PJ, et al. (2009) Tyrosine and
serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity
and soluble oligomer formation. J Clin Invest 119: 3257–3265.
9. Humbert S, Bryson EA, Cordelie `res FP, Connors NC, Datta SR, et al. (2002)
The IGF-1/Akt pathway is neuroprotective in Huntington’s disease and involves
Huntingtin phosphorylation by Akt. Dev Cell 2: 831–837.
10. Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, et al. (2009) Serines 13 and
16 are critical determinants of full-length human mutant huntingtin induced
disease pathogenesis in HD mice. Neuron 64: 828–840.
11. Palaiologos G, Hertz L, Schousboe A (1988) Evidence that aspartate
aminotransferase activity and ketodicarboxylate carrier function are essential
for biosynthesis of transmitter glutamate. J Neurochem 51: 317–320.
12. Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, et al. (1998)
Hyperinsulinism and hyperammonemia in infants with regulatory mutations of
the glutamate dehydrogenase gene. N Engl J Med 338: 1352–1357.
13. Anggono V, Smillie KJ, Graham ME, Valova VA, Cousin MA, et al. (2006)
Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic
vesicle endocytosis. Nat Neurosci 9: 752–760.
14. Modregger J, Ritter B, Witter B, Paulsson M, Plomann M (2000) All three
PACSIN isoforms bind to endocytic proteins and inhibit endocytosis. J Cell Sci
113 Pt 24: 4511–4521.
15. Modregger J, DiProspero NA, Charles V, Tagle DA, Plomann M (2002)
PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in
presymptomatic Huntington’s disease brains. Hum Mol Genet 11: 2547–
2558.
16. Sutton RB, Fasshauer D, Jahn R, Brunger AT (1998) Crystal structure of a
SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 395:
347–353.
17. Sørensen JB, Wiederhold K, Mu ¨ller EM, Milosevic I, Nagy G, et al. (2006)
Sequential N- to C-terminal SNARE complex assembly drives priming and
fusion of secretory vesicles. EMBO J 25: 955–966.
18. Verderio C, Pozzi D, Pravettoni E, Inverardi F, Schenk U, et al. (2004) SNAP-
25 modulation of calcium dynamics underlies differences in GABAergic and
glutamatergic responsiveness to depolarization. Neuron 41: 599–610.
19. Sang Lee J, Gyu Park S, Park H, Seol W, Lee S, et al. (2002) Interaction network
of human aminoacyl-tRNA synthetases and subunits of elongation factor 1
complex. Biochem Biophys Res Commun 291: 158–164.
20. Vandamme HTF, Amons R, Karssies R, Timmers CJ, Janssen GMC, et al.
(1990) Elongation Factor-1-Beta of Artemia - Localization of functional sites and
homology to Elongation Factor -1-Delta. Biochimica Et Biophysica Acta 1050:
241–247.
21. Peters HI, Chang YW, Traugh JA (1995) Phosphorylation of elongation factor 1
(EF-1) by protein kinase C stimulates GDP/GTP-exchange activity.
Eur J Biochem 234: 550–556.
Figure 7. The formula for calculating the postmortem time at
room temperature. The formula was based on the characters of
Pacsin1 and Gm5506. Pacsin1 decreases at a constant rate at room
temperature but it is stable at 4uC for 72 hrs. In contrast, Gm5506 is
stable both at room temperature and 4uC. The ratio between Pacsin1
and Gm5506 at 0 hr (76.1:75.1) is also known. If the ratio between
Pacsin1 and Gm5506 at 0 hr in fresh human brain samples is known, we
can calculate the postmortem time at RT in human brain with the
formula.
doi:10.1371/journal.pone.0021405.g007
Postmortem Change of Brain Phosphoproteome
PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e2140522. Katashima R, Iwahana H, Fujimura M, Yamaoka T, Ishizuka T, et al. (1998)
Molecular cloning of a human cDNA for the 41-kDa phosphoribosylpyrophos-
phate synthetase-associated protein. Biochim Biophys Acta 1396: 245–250.
23. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, et al. (1987) The
precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface
receptor. Nature 325: 733–736.
24. Tarr PE, Contursi C, Roncarati R, Noviello C, Ghersi E, et al. (2002) Evidence
for a role of the nerve growth factor receptor TrkA in tyrosine phosphorylation
and processing of beta-APP. Biochem Biophys Res Commun 295: 324–329.
25. Tarr PE, Roncarati R, Pelicci G, Pelicci PG, D’Adamio L (2002) Tyrosine
phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes
interaction with Shc. J Biol Chem 277: 16798–16804.
26. Russo C, Dolcini V, Salis S, Venezia V, Zambrano N, et al. (2002) Signal
transduction through tyrosine-phosphorylated C-terminal fragments of amyloid
precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins
in reactive astrocytes of Alzheimer’s disease brain. J Biol Chem 277:
35282–35288.
27. Takahashi K, Niidome T, Akaike A, Kihara T, Sugimoto H (2008)
Phosphorylation of amyloid precursor protein (APP) at Tyr687 regulates APP
processing by alpha- and gamma-secretase. Biochem Biophys Res Commun
377: 544–549.
28. Kang DE, Soriano S, Xia X, Eberhart CG, De Strooper B, et al. (2002)
Presenilin couples the paired phosphorylation of beta-catenin independent of
axin: implications for beta-catenin activation in tumorigenesis. Cell 110:
751–762.
29. Kuo LH, Hu MK, Hsu WM, Tung YT, Wang BJ, et al. (2008) Tumor necrosis
factor-alpha-elicited stimulation of gamma-secretase is mediated by c-Jun N-
terminal kinase-dependent phosphorylation of presenilin and nicastrin. Mol Biol
Cell 19: 4201–4212.
30. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung YC, et al. (1989)
Identification and localization of a tau peptide to paired helical filaments of
Alzheimer disease. Proc Natl Acad Sci U S A 86: 5646–5650.
31. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, et al. (1986)
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in
Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83: 4913–4917.
32. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, et
al. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased
frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl
Acad Sci U S A 90: 1977–1981.
33. Chang KH, de Pablo Y, Lee HP, Lee HG, Smith MA, et al. (2010) Cdk5 is a
major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s
disease. J Neurochem 113: 1221–1229.
34. Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, et al. (2009)
Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies.
Acta Neuropathol 117: 125–136.
35. Noble W, Planel E, Zehr C, Olm V, Meyerson J, et al. (2005) Inhibition of
glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and
degeneration in vivo. Proc Natl Acad Sci U S A 102: 6990–6995.
36. Okochi M, Walter J, Koyama A, Nakajo S, Baba M, et al. (2000) Constitutive
phosphorylation of the Parkinson’s disease associated alpha-synuclein. J Biol
Chem 275: 390–397.
37. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997)
Mutation in the alpha-synuclein gene identified in families with Parkinson’s
disease. Science 276: 2045–2047.
38. Greggio E, Taymans JM, Zhen EY, Ryder J, Vancraenenbroeck R, et al. (2009)
The Parkinson’s disease kinase LRRK2 autophosphorylates its GTPase domain
at multiple sites. Biochem Biophys Res Commun 389: 449–454.
39. Mortiboys H, Johansen KK, Aasly JO, Bandmann O (2010) Mitochondrial
impairment in patients with Parkinson disease with the G2019S mutation in
LRRK2. Neurology 75: 2017–2020.
40. Andersson FI, Werrell EF, McMorran L, Crone WJ, Das C, et al. (2011) The
Effect of Parkinson’s-Disease-Associated Mutations on the Deubiquitinating
Enzyme UCH-L1. J Mol Biol 407: 261–72.
41. Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF, et al. (2011) Novel
regulation of Parkin function through c-Abl-mediated tyrosine phosphorylation:
implications for Parkinson’s disease. J Neurosci 31: 157–163.
42. Kim Y, Park J, Kim S, Song S, Kwon SK, et al. (2008) PINK1 controls
mitochondrial localization of Parkin through direct phosphorylation. Biochem
Biophys Res Commun 377: 975–980.
43. Lautier C, Goldwurm S, Du ¨rr A, Giovannone B, Tsiaras WG, et al. (2008)
Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial
Parkinson disease. Am J Hum Genet 82: 822–833.
44. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, et al.
(2005) Loss of function mutations in the gene encoding Omi/HtrA2 in
Parkinson’s disease. Hum Mol Genet 14: 2099–2111.
Postmortem Change of Brain Phosphoproteome
PLoS ONE | www.plosone.org 10 June 2011 | Volume 6 | Issue 6 | e21405